Publications by authors named "Andreas Lohri"

33Publications

Prolonged rituximab maintenance in follicular lymphoma patients: long-term results of the SAKK 35/03 randomized trial.

Authors:
Alden A Moccia Christian Taverna Sämi Schär Anna Vanazzi Stéphanie Rondeau Felicitas Hitz Walter Mingrone Thomas Pabst Lidija Cevreska Auro Del Giglio Johann Raats Daniel Rauch Daniel A Vorobiof Andreas Lohri Céline Ruegsegger Christine Biaggi Rudolf Corinne Rusterholz Stefanie Hayoz Michele Ghielmini Emanuele Zucca

Blood Adv 2020 Dec;4(23):5951-5957

Oncology Institute of Southern Switzerland, Medical Oncology Clinic, Ospedale San Giovanni, Bellinzona, Switzerland.

View Article and Find Full Text PDF
December 2020

Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.

Authors:
Rudolf Benz Kornelius Arn Martin Andres Thomas Pabst Michael Baumann Urban Novak Felicitas Hitz Urs Hess Reinhard Zenhaeusern Yves Chalandon Ulrich Mey Sabine Blum Daniel Rauch Alix O'Meara Stern Nathan Cantoni Mario Bargetzi Elena Bianchi-Papina Davide Rossi Jakob Passweg Andreas Lohri Simona Berardi Qiyu Li Anita Feller Georg Stussi

Blood Adv 2020 Aug;4(15):3699-3707

Department of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

View Article and Find Full Text PDF
August 2020

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.

Authors:
Michael Fuchs Helen Goergen Carsten Kobe Georg Kuhnert Andreas Lohri Richard Greil Stephanie Sasse Max S Topp Erhardt Schäfer Bernd Hertenstein Martin Soekler Martin Vogelhuber Josée M Zijlstra Ulrich Bernd Keller Stefan W Krause Martin Wilhelm Georg Maschmeyer Julia Thiemer Ulrich Dührsen Julia Meissner Andreas Viardot Hans Eich Christian Baues Volker Diehl Andreas Rosenwald Bastian von Tresckow Markus Dietlein Peter Borchmann Andreas Engert

J Clin Oncol 2019 11 10;37(31):2835-2845. Epub 2019 Sep 10.

German Hodgkin Study Group (GHSG), Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.

View Article and Find Full Text PDF
November 2019

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.

Authors:
Emanuele Zucca Stephanie Rondeau Anna Vanazzi Bjørn Østenstad Ulrich J M Mey Daniel Rauch Björn E Wahlin Felicitas Hitz Micaela Hernberg Ann-Sofie Johansson Peter de Nully Brown Hans Hagberg Andrés J M Ferreri Andreas Lohri Urban Novak Thilo Zander Hanne Bersvendsen Mario Bargetzi Walter Mingrone Fatime Krasniqi Stefan Dirnhofer Stefanie Hayoz Hanne Hawle Simona Berardi Vilei Michele Ghielmini Eva Kimby

Blood 2019 07 17;134(4):353-362. Epub 2019 May 17.

Unit of Hematology, Department of Medicine at Huddinge, Karolinska Institutet, Stockholm, Sweden.

View Article and Find Full Text PDF
July 2019

Diagnosis and treatment of follicular lymphoma: an update.

Authors:
Mario Bargetzi Reto Baumann Sergio Cogliatti Pierre-Yves Dietrich Michel Duchosal Jeroen Goede Felicitas Hitz Carolin Konermann Andreas Lohri Ulrich Mey Urban Novak Alexandros Papachristofilou Frank Stenner Christian Taverna Thilo Zander Christoph Renner

Swiss Med Wkly 2018;148:w14635. Epub 2018 Jul 24.

Onkozentrum Hirslanden & Zürich, Zürich, Switzerland.

View Article and Find Full Text PDF
December 2018

Dyslipidemia and lipid-lowering treatment in a hematopoietic stem cell transplant cohort: 25 years of follow-up data.

Authors:
Melanie Premstaller Melanie Perren Kuebra Koçack Christian Arranto Geneviève Favre Andreas Lohri Sabine Gerull Jakob R Passweg Jörg P Halter Anne B Leuppi-Taegtmeyer

J Clin Lipidol 2018 Mar - Apr;12(2):464-480.e3. Epub 2017 Dec 6.

Department of Clinical Pharmacology and Toxicology, University Hospital Basel and University of Basel, Basel, Switzerland. Electronic address:

View Article and Find Full Text PDF
September 2019

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.

Authors:
Peter Borchmann Helen Goergen Carsten Kobe Andreas Lohri Richard Greil Dennis A Eichenauer Josée M Zijlstra Jana Markova Julia Meissner Michaela Feuring-Buske Andreas Hüttmann Judith Dierlamm Martin Soekler Hans-Joachim Beck Wolfgang Willenbacher Wolf-Dieter Ludwig Thomas Pabst Max S Topp Felicitas Hitz Martin Bentz Ulrich Bernd Keller Dagmar Kühnhardt Helmut Ostermann Norbert Schmitz Bernd Hertenstein Walter Aulitzky Georg Maschmeyer Tom Vieler Hans Eich Christian Baues Harald Stein Michael Fuchs Georg Kuhnert Volker Diehl Markus Dietlein Andreas Engert

Lancet 2018 12 20;390(10114):2790-2802. Epub 2017 Oct 20.

German Hodgkin Study Group, Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany.

View Article and Find Full Text PDF
December 2018

Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPP alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.

Authors:
Peter Borchmann Heinz Haverkamp Andreas Lohri Ulrich Mey Stefanie Kreissl Richard Greil Jana Markova Michaela Feuring-Buske Julia Meissner Ulrich Dührsen Helmut Ostermann Ulrich Keller Georg Maschmeyer Georg Kuhnert Markus Dietlein Carsten Kobe Hans Eich Christian Baues Harald Stein Michael Fuchs Volker Diehl Andreas Engert

Lancet Oncol 2017 04 22;18(4):454-463. Epub 2017 Feb 22.

Department of Internal Medicine I, University Hospital of Cologne, Cologne, Germany; German Hodgkin Study Group, Cologne, Germany.

View Article and Find Full Text PDF
April 2017

[Lymphomas].

Authors:
Andreas Lohri

Praxis (Bern 1994) 2016 Jan;105(1):47-52

1 Onkologie, Hämatologie & Immuntherapie, Medizinische Universitätsklinik, Kantonsspital Baselland, Liestal.

View Article and Find Full Text PDF
January 2016

Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.

Authors:
Christian Taverna Giovanni Martinelli Felicitas Hitz Walter Mingrone Thomas Pabst Lidija Cevreska Auro Del Giglio Anna Vanazzi Daniele Laszlo Johann Raats Daniel Rauch Daniel A Vorobiof Andreas Lohri Christine Biaggi Rudolf Stéphanie Rondeau Corinne Rusterholz Ingmar A F M Heijnen Emanuele Zucca Michele Ghielmini

J Clin Oncol 2016 Feb 28;34(5):495-500. Epub 2015 Dec 28.

Christian Taverna, Kantonsspital Münsterlingen, Münsterlingen; Felicitas Hitz, Kantonsspital St Gallen, St Gallen; Walter Mingrone, Kantonsspital Aarau/Olten, Olten; Thomas Pabst, Inselspital Bern; Christine Biaggi Rudolf, Stéphanie Rondeau, and Corinne Rusterholz, Swiss Group for Clinical Cancer Research SAKK, Bern; Daniel Rauch, Spital Thun Simmental, Thun; Andreas Lohri, Kantonsspital Liestal, Liestal; Ingmar A.F.M. Heijnen, University Hospital Basel, Basel; Emanuele Zucca and Michele Ghielmini, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland; Giovanni Martinelli, Anna Vanazzi, and Daniele Laszlo, Istituto Europeo di Oncologia, Milan, Italy; Lidija Cevreska, University Clinic for Hematology, Skopje, Macedonia; Auro del Giglio, ABC Fondation School of Medicine, Sao Paulo, Brazil; Johann Raats, Panorama Oncology Unit, Cape Town; and Daniel A. Vorobiof, Sandton Oncology Center, Johannesburg, South Africa.

View Article and Find Full Text PDF
February 2016

Survival in overweight patients with advanced pancreatic carcinoma: a multicentre cohort study.

Authors:
Benjamin Kasenda Annatina Bass Dieter Koeberle Bernhard Pestalozzi Markus Borner Richard Herrmann Lorenz Jost Andreas Lohri Viviane Hess

BMC Cancer 2014 Sep 29;14:728. Epub 2014 Sep 29.

Department of Medical Oncology, University Hospital Basel, Petersgraben 4, Basel CH-4031, Switzerland.

View Article and Find Full Text PDF
September 2014

The advent of biosimilars: challenges and risks.

Authors:
Rüdiger Müller Christoph Renner Cem Gabay Giuseppe Cassata Andreas Lohri Paul Hasler

Swiss Med Wkly 2014 1;144:w13980. Epub 2014 Jul 1.

Kantonsspital Aarau, Aarau, Switzerland.

View Article and Find Full Text PDF
February 2015

Diagnosis and treatment of mantle cell lymphoma.

Authors:
Felicitas Hitz Mario Bargetzi Sergio Cogliatti Andreas Lohri Christian Taverna Christoph Renner Ulrich Mey

Swiss Med Wkly 2013 13;143:w13868. Epub 2013 Nov 13.

Kantonsspital St.Gallen, SWITZERLAND;

View Article and Find Full Text PDF
June 2014

Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas.

Authors:
Flavio Forrer Catharina Oechslin-Oberholzer Benedetta Campana Richard Herrmann Helmut R Maecke Jan Mueller-Brand Andreas Lohri

J Nucl Med 2013 Jul 9;54(7):1045-52. Epub 2013 Apr 9.

Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

View Article and Find Full Text PDF
July 2013

Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma.

Authors:
Stephanie Sasse Achim Rothe Helen Goergen Dennis A Eichenauer Andreas Lohri Stephan Kreher Ulrich Jäger Christopher Bangard Georg Kuhnert Boris Böll Bastian von Tresckow Andreas Engert

Leuk Lymphoma 2013 Oct 27;54(10):2144-8. Epub 2013 Mar 27.

First Department of Internal Medicine.

View Article and Find Full Text PDF
October 2013

Brentuximab vedotin for relapsed or refractory CD30+ hematologic malignancies: the German Hodgkin Study Group experience.

Authors:
Achim Rothe Stephanie Sasse Helen Goergen Dennis A Eichenauer Andreas Lohri Ulrich Jäger Christopher Bangard Boris Böll Michael von Bergwelt Baildon Sebastian Theurich Peter Borchmann Andreas Engert

Blood 2012 Aug 11;120(7):1470-2. Epub 2012 Jul 11.

First Department of Internal Medicine, University Hospital of Cologne, Kerpener Strasse 62, Cologne, Germany.

View Article and Find Full Text PDF
August 2012

A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma.

Authors:
Christoph Renner Pier Luigi Zinzani Rémy Gressin Dirk Klingbiel Pierre-Yves Dietrich Felicitas Hitz Mario Bargetzi Walter Mingrone Giovanni Martinelli Andreas Trojan Krimo Bouabdallah Andreas Lohri Emmanuel Gyan Christine Biaggi Sergio Cogliatti Francesco Bertoni Michele Ghielmini Peter Brauchli Nicolas Ketterer

Haematologica 2012 Jul 7;97(7):1085-91. Epub 2012 Feb 7.

Division of Oncology, University Hospital Zürich, Rämistrasse 100 8091 Zürich, Switzerland.

View Article and Find Full Text PDF
July 2012

Diagnosis and treatment of diffuse large B-cell lymphoma.

Authors:
Ulrich Mey Felicitas Hitz Andreas Lohri Stefanie Pederiva Christian Taverna Alexander Tzankov Oliver Meier Karen Yeow Christoph Renner

Swiss Med Wkly 2012 30;142:w13511. Epub 2012 Jan 30.

Medical Oncology and Haematology, Cantonal Hospital of Graubuenden, Loestrasse 170, Chur, Switezrland.

View Article and Find Full Text PDF
May 2012

Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.

Authors:
Bastian von Tresckow Annette Plütschow Michael Fuchs Beate Klimm Jana Markova Andreas Lohri Zdenek Kral Richard Greil Max S Topp Julia Meissner Josée M Zijlstra Martin Soekler Harald Stein Hans T Eich Rolf P Mueller Volker Diehl Peter Borchmann Andreas Engert

J Clin Oncol 2012 Mar 23;30(9):907-13. Epub 2012 Jan 23.

University of Cologne, Cologne, Germany.

View Article and Find Full Text PDF
March 2012

Diagnosis and treatment of follicular lymphoma.

Authors:
Felicitas Hitz Nicolas Ketterer Andreas Lohri Ulrich Mey Stefanie Pederiva Christoph Renner Christian Taverna Anna Hartmann Karen Yeow Stephan Bodis Emanuele Zucca

Swiss Med Wkly 2011 4;141:w13247. Epub 2011 Aug 4.

Onkologie/Hämatologie, Kantonsspital St. Gallen, Rorschacherstrasse, 9000 St. Gallen, Switzerland.

View Article and Find Full Text PDF
December 2011